on the severity of nephritis 1985 christopher bunch, is gene switching a feasible approach to the treatment of genetic disease 1986 adrian l harris, from molecular biology to cancer treatment: cancer medicine. 1987 1988 david linch 1989 1990 anthony michael heagerty 1991 paul anthony weetman, autoimmune thyroid disease 1992 douglass turnbull, 1993 1994 jayne franklyn 1995 philip n. hawkins, the diagnosis, natural history and treatment of amyloidosis 1996 patrick vallance exploring vascular nitric oxide in health and disease 1997 paul stewart cortisol, hypertension and obesity – "it’s my metabolism, doctor" 1998 hugh christian watkins 1999 christopher p. day 2000 john mcgrath sheila sherlock (1918-2001) 2001 – present 2001 patrick h. maxwell 2002 d. e. j. jones, addison’s other disease: primary biliary cirrhosis as a model autoimmune disease 2003 michael g. f. hanna, neurological channelopathies: a new field 2004 2005 andrew catto, genes, haemostasis and vascular disease – insights into disease mechanisms 2006 neil gittoes, pituitary tumours – deciphering pathogenesis and optimising treatment 2007 rebecca fitzgerald, is prevention better than cure for oesophageal cancer? 2008 matthew david rutter 2009 geraint rees, decoding consciousness 2010 waljit dhillo, the critical role of kisspeptin in human fertility 2011 srinivasan madhusudan, targeting dna base excision repair for personalisation of cancer therapy 2012 2013 2014 charles swanton, cancer evolution through space and time: causes and consequences of cancer diversity 2015 2016 martin r. turner, motor neurone disease - biomarker development for an expanding cerebral syndrome 2017 gideon hirschfield (planned) 2018 miratul muqit (planned) 2019 mona bafadhel eosinophils in copd: a breakthrough in patient management (feb 2019) 2020 sarosh irani "defining clinical and molecular characteristics of treatable diseases at the neuroimmunological synapse" "oxford clinician scientist receives prestigious medical prize".